Anand Sampath, EVP, Operations & Clinical Research at MASIMO CORP (MASI), sold 18,680 shares at $136.56 ($2.6M) on 2026-01-28, disclosed to the SEC on 2026-01-30.
Seasonal sale ($2.6M) by EVP, Operations & Clinical Research — this insider has traded MASI in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.56 | 11,924 | $1.6M | 63.7% |
| 2 | $137.22 | 6,560 | $900K | 35.2% |
| 3 | $138.09 | 196 | $27K | 1.1% |
| Total | $136.81 avg | 18,680 | $2.6M | 100% |
| Filing → |
| MASI | SELL | 2019-11-21 | $2.3M | — | Filing → |
| MASI | SELL | 2019-06-18 | $4.3M | — | Filing → |
| MASI | SELL | 2019-01-16 | $3.5M | — | Filing → |